96 research outputs found

    Influence of suspension viscosity on Brownian relaxation of filler particles

    Get PDF
    Brownian relaxation caused by Brownian movement of particles in suspensions can macroscopically be probed by small-amplitude oscillatory shear experiments. Phenomenological considerations suggest a direct proportionality between suspension viscosity and Brownian relaxation times. To verify this relation experimentally, a set of nanocomposite suspensions with viscosities varying over five decades is presented. The suspensions are chosen in a way to ensure that particle-particle interactions and average particle-particle distances are identical so that they can be used as a model system to study the mere influence of suspension viscosity on Brownian relaxation. The suggested linear relationship between suspension viscosity and Brownian relaxation time can be confirmed. Moreover, a verification of a recently introduced characteristic timescale for Brownian relaxation is presented

    Ageing, dynamical scaling and its extensions in many-particle systems without detailed balance

    Full text link
    Recent studies on the phenomenology of ageing in certain many-particle systems which are at a critical point of their non-equilibrium steady-states, are reviewed. Examples include the contact process, the parity-conserving branching-annihilating random walk, two exactly solvable particle-reaction models and kinetic growth models. While the generic scaling descriptions known from magnetic system can be taken over, some of the scaling relations between the ageing exponents are no longer valid. In particular, there is no obvious generalization of the universal limit fluctuation-dissipation ratio. The form of the scaling function of the two-time response function is compared with the prediction of the theory of local scale-invariance.Comment: Latex2e with IOP macros, 32 pages; extended discussion on contact process and new section on kinetic growth processe

    Effective field theory analysis of the self-interacting chameleon

    Full text link
    We analyse the phenomenology of a self-interacting scalar field in the context of the chameleon scenario originally proposed by Khoury and Weltman. In the absence of self-interactions, this type of scalar field can mediate long range interactions and simultaneously evade constraints from violation of the weak equivalence principle. By applying to such a scalar field the effective field theory method proposed for Einstein gravity by Goldberger and Rothstein, we give a thorough perturbative evaluation of the importance of non-derivative self-interactions in determining the strength of the chameleon mediated force in the case of orbital motion. The self-interactions are potentially dangerous as they can change the long range behaviour of the field. Nevertheless, we show that they do not lead to any dramatic phenomenological consequence with respect to the linear case and solar system constraints are fulfilled.Comment: 15 pages, 2 figures. Final version accepted for publication on General Relativity and Gravitatio

    Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

    Get PDF
    Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

    Glassy behaviours in a-thermal systems, the case of granular media: A tentative review

    No full text
    International audienceno abstrac
    • …
    corecore